The mRNA synthesis and manufacturing market is projected to be worth USD 1.5 billion by 2035 rootsanalysis.com
Given the current technical and operational challenges associated with the manufacturing of mRNA-based products, innovators in the biopharmaceutical industry are increasingly relying on the mRNA synthesis and contract manufacturing service providers.
Report Story
Leave Your Comment